about
A Small-Molecule Inhibitor of BCL6 Kills DLBCL Cells In Vitro and In VivoB-cell lymphoma 6 protein stimulates oncogenicity of human breast cancer cellsExpression of leukemia/lymphoma-related factor (LRF/POKEMON) in human breast carcinoma and other cancers.Negative autoregulation of BCL-6 is bypassed by genetic alterations in diffuse large B cell lymphomas.Suppression of human B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin involves altered regulation of B cell lymphoma-6.Diagnostic application of FISH to hematological malignancies.Targeting protein-protein interactions in hematologic malignancies: still a challenge or a great opportunity for future therapies?The epidemiology of non-Hodgkin's lymphoma.Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomasB-cell lymphoma 6 and the molecular pathogenesis of diffuse large B-cell lymphoma.Hepatitis viruses and non-Hodgkin's lymphoma: A reviewAn essential EBV latent antigen 3C binds Bcl6 for targeted degradation and cell proliferation.Epstein-Barr virus represses the FoxO1 transcription factor through latent membrane protein 1 and latent membrane protein 2AMicroRNA-187 induces diffuse large B-cell lymphoma cell apoptosis via targeting BCL6.BCL6-mediated attenuation of DNA damage sensing triggers growth arrest and senescence through a p53-dependent pathway in a cell context-dependent manner.High expressions of BCL6 and Lewis y antigen are correlated with high tumor burden and poor prognosis in epithelial ovarian cancer.
P2860
Q27660498-51A728A2-E41E-4F80-89AC-9FCC1222ED6CQ33786387-1843ED40-AEBF-4E2B-A2BA-26E4D1A712E7Q34127284-B08C5AE8-3BCF-4E2A-BD1F-9AF6A1E900BEQ34380954-FC4059DD-2FE3-46FA-8FA0-6E02E74DE5B6Q35145901-8576BC33-CAB7-4141-B552-8ACAC78E8599Q35589218-9ADCA019-0037-4378-9BE3-8B051FC17387Q35687836-B6D18966-4D28-411C-95FC-950B9BE0F7FDQ35868057-C9FAB8D8-E33A-4DFA-A478-EFBE34858B5AQ36407235-B08233B3-6E05-467C-A983-BF25D9434840Q37184358-1449A359-E8D0-40DA-88D9-86A5DACA33D8Q37195543-FD1AA198-B1B0-4EDC-8352-EBB36F0B7DA5Q38664787-2EEB0519-6EEC-4F3A-9EE6-5A6AA391EDE0Q39304933-78DB148B-A4BD-48A2-995A-6A1E420C49BBQ39647418-9E94279A-DE6D-46D5-A5C3-0983B12429F4Q39975326-3E78BDBD-B0B7-4FCB-A4A0-2DD57CEBA1A1Q48625336-9B2CEEEE-628D-45F9-B84E-EC1A28C9F693
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
BCL-6 in the pathogenesis of non-Hodgkin's lymphoma.
@ast
BCL-6 in the pathogenesis of non-Hodgkin's lymphoma.
@en
type
label
BCL-6 in the pathogenesis of non-Hodgkin's lymphoma.
@ast
BCL-6 in the pathogenesis of non-Hodgkin's lymphoma.
@en
prefLabel
BCL-6 in the pathogenesis of non-Hodgkin's lymphoma.
@ast
BCL-6 in the pathogenesis of non-Hodgkin's lymphoma.
@en
P2860
P1433
P1476
BCL-6 in the pathogenesis of non-Hodgkin's lymphoma.
@en
P2093
P2860
P304
P356
10.3109/07357900009012179
P577
2000-01-01T00:00:00Z